There are 2789 resources available
Do we have any idea how to use these drugs in oncogene addicted patients yet?
Presenter: Julien Mazieres
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast
Introduction
Presenter: Sanjay Popat
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Broadening the horizons: EGFR, ALK, ROS-1, BRAF
Presenter: Christine Lovly
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Webcast
Opening new horizons: RET, NTRK, MET, HER2…
Presenter: Herbert Ho Fung Loong
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Webcast
How do we identify resistance mechanisms?
Presenter: Joop De Langen
Session: The year in review of molecularly driven NSCLC
Resources:
Slides
Webcast
Discoveries in T-cell antigen receptor (TCR) recognition
Presenter: Tak Mak
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Introduction
Presenter: Sebastian Kobold
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Overview on synthetic immune receptors
Presenter: Hinrich Abken
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Resistance mechanisms to T-cells in solid tumours
Presenter: Crystal Mackall
Session: Synthetic immune therapy
Resources:
Slides
Webcast
Clinical experience with radiotherapy plus immune checkpoint inhibitors
Presenter: Jean Bourhis
Session: The emerging role of immunotherapy in the curative setting
Resources:
Slides
Webcast